Molecular Breast Imaging Proves Cost-Effective for Presurgical Planning in Patients with Breast Cancer

Tuesday, December 2, 2008 General News J E 4
CHICAGO, Dec. 1 Breast-Specific Gamma Imaging (BSGI), amolecular breast imaging technique that is substantially less expensive thanbreast magnetic resonance imaging (MRI) with comparable sensitivity fordetecting breast carcinoma when used in presurgical planning for patients withknown cancer diagnoses, according to findings presented today at the annualmeeting of the Radiological Society of North America (RSNA).

"According to the national Medicare average, BSGI costs $219.43 comparedto $994.43 for breast MRI. Since BSGI has some advantages over MRI, includinghigher patient tolerance and significant cost savings, BSGI should beconsidered an alternative for preoperative planning in patients with breastcarcinoma," said Dr. Margaret Bertrand, Director of Breast Imaging at SolisBertrand Breast Center in Greensboro, N.C.

In this study, BSGI was performed prior to needle biopsy on 63 patientswith 64 breast malignancies who subsequently had a post-biopsy, preoperativebreast MRI for surgical planning in accordance with the ACS guidelines. Of the64 malignancies, BSGI and MRI were positive in 61 and 62 lesions,respectively. BSGI and MRI were comparable in sensitivity for breastcarcinoma, 95 percent and 97 percent respectively. Unlike MRI, BSGI wastolerated by all patients.

BSGI for the study was conducted using a Dilon 6800 Gamma Camera, ahigh-resolution, small field-of-view gamma camera, optimized to perform BSGI.BSGI is a molecular breast imaging technique that can see lesions independentof tissue density and discover very early stage cancers. With BSGI, thepatient receives a pharmaceutical tracing agent that is absorbed by all thecells in the body. Due to their increased rate of metabolic activity,cancerous cells in the breast absorb a greater amount of the tracing agentthan the normal surrounding tissue and generally appear as "hot spots" on theBSGI image.

About Dilon Technologies

Dilon Technologies Inc. is bringing innovative new medical imagingproducts to market. Dilon's cornerstone product, the Dilon 6800, is ahigh-resolution, small field-of-view gamma camera, optimized to perform BSGI,a molecular breast imaging procedure which images the metabolic activity ofbreast lesions through radiotracer uptake. Many leading medical centers aroundthe country are now offering BSGI to their patients, including: CornellUniversity Medical Center, New York; George Washington University MedicalCenter, Washington, D.C.; and The Rose, Houston.

For more information on Dilon Technologies please visit

SOURCE Dilon Technologies Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Molecular Breast Imaging Performs Better Than Ultr...
TFAH Statement: FDA Food Protection Plan is Insuff...